Proactive Investors - Run By Investors For Investors

1933 Industries bolsters cannabis extraction capacity at Las Vegas facility

The company plans to expand its production area to 2,215 square feet from 483 square feet, doubling its distillate production capacity
Las Vegas cultivation facility
Once its cannabis plants are moved to a new cultivation facility, the company will submit layout plans to the city of Las Vegas for approval

1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF) is ramping up extraction of cannabis concentrates at its cultivation facility in Nevada.

The company plans to build improvements at the Alternative Medicine Association cultivation facility in Las Vegas to expand its production area to 2,215 square feet from 483 square feet, doubling its potential production capacity to 80 liters of distillate per month.

Once its cannabis plants are moved to a new cultivation facility, the company will submit layout plans to the city of Las Vegas for approval. The operation is expected to kick into gear in the fall of 2019.

READ: 1933 Industries gets permanent occupancy permit for Las Vegas cultivation facility

Additionally, the Vancouver-based company is working with an engineering firm on custom equipment to establish one of Nevada’s largest hemp-extraction facilities. The operation will be capable of isolating cannabidiol, cannabinol, cannabigerol, cannabichromene and several other cannabinoids to create oils and isolates.

The company has ordered its custom and is working on the final layout. Its processing capacity is expected to be roughly 68,000 kilograms of hemp biomass per month, which would yield about 5,000 kilograms of oils or 4,500 kilograms of CBD isolate.

"The process has been scaled up after a lengthy research phase, where we aimed to create a method of extraction using specialized chemistry and equipment in order to obtain a higher yield of CBD, thus increasing our efficiency,” CEO Chris Rebentisch said. “The competitive advantage of the new facility will be the isolation of not only CBD but of additional individual cannabinoids at scale, which is unique and novel in the cannabis marketplace."

The company's stock slid 2.4% on Friday to C$0.41 on the CSE and 2.6% to US$0.31 on OTC Markets. 

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TGIF profile View Profile

1933 Industries Timeline

Related Articles

cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
A WeedMD greenhouse
January 21 2019
WeedMD produces cannabis and cannabis oil for both the medical and adult-use markets
data graphic
March 22 2019
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use